DNM-30319-95456
3 vaccinations
1 coded response
20 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 278 / NC
- Registered
- 2021-02-04
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-28
Dose 1 — Moderna
-
2021-02-04
Registered in v-safe
- 2021-02-04
- 2021-02-13
- 2021-02-18
-
2021-02-24
Dose 2 — Moderna
-
2021-02-25
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Fever · HeadacheAdult check-in
- 2021-02-26
- 2021-02-27
- 2021-02-28
-
2021-03-01
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Headache, Diarrhea · Be unable to workAdult check-in
- 2021-03-02
- 2021-03-03
- 2021-03-19
- 2021-03-26
- 2021-03-31
- 2021-04-09
- 2021-05-26
- 2021-08-27
-
2021-10-30
Dose 3 — ModernaCo-administered: Flu
-
2021-11-02
Survey response — days 1–6 daily, dose 3MedDRA: Nasopharyngitis — Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessFree text: ColdMedDRA releases: 2024-11 · check-in free text available
-
2021-11-03
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, NauseaAdult check-in
- 2021-11-05
- 2021-12-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-28 | Moderna | |
| 2 | 2021-02-24 | Moderna | |
| 3 | 2021-10-30 | Moderna | Flu |
Free text
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Cold
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Nasopharyngitis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release